title: Thyroid arsenic content and papillary thyroid carcinoma arising 10 years after oral arsenic trioxide therapy for refractory acute promyelocytic leukemia.
authors: Blood-med Clinic , Hong Kong.
authors: Wing-yan
authors: WY
authors: Au
authors: Brian H
authors: BH
authors: Lang
authors: Bonnie M W
authors: BM
authors: Fong
authors: Kevin J
authors: KJ
authors: Mao
authors: Sidney
authors: S
authors: Tam
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000009:adverse effects* / Q000627:therapeutic use; D002277:Carcinoma / Q000175:diagnosis / Q000209:etiology*; D002291:Carcinoma, Papillary; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000150:complications* / Q000188:drug therapy; D016609:Neoplasms, Second Primary / Q000175:diagnosis / Q000209:etiology*; D010087:Oxides / Q000009:adverse effects* / Q000627:therapeutic use; D000077273:Thyroid Cancer, Papillary; D013961:Thyroid Gland / Q000378:metabolism; D013964:Thyroid Neoplasms / Q000175:diagnosis / Q000209:etiology*; D055815:Young Adult
chemical_list: D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D000077237:Arsenic Trioxide